Coming EventsSee past events
ITOC6 Conference (2019)
The 6th Immunotherapy of Cancer Conference (ITOC6) organised by the Cancer Drug Development Forum and the Society for Immunotherapy of Cancer (SITC) aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research. The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
13th International Gastric Cancer Congress
Research on gastric cancer is developing fast. New insights into tumor biology and progress in health care delivery allow for more precise diagnostics, more efficacious treatment and better quality of care. This is more than one reason to profit from this most important and biggest scientific meeting on the topic of gastric cancer worldwide, bringing together delegates from many disciplines, reaching from basic researchers, clinical scientists and physicians from all disciplines and other health care professionals.
More information on the conference website.
5th EORTC Quality of Life
It is our pleasure to invite you to the 5th EORTC Quality of Life in Cancer Clinical Trials Conference which will be held in 2019. This event will give participants the opportunity to learn about the latest topics in quality of life (QOL) and patient reported outcomes research. The two-day conference aims to bring together over 30 of the world’s most influential QOL researchers. There will be presentations on current state-of-the-art methods for instrument development and QOL measurement in international cancer clinical trials, addressing a variety of topics from designing robust measures to understanding their clinical meaning. Discussions on new tools and emerging technologies that have the potential to change the way we measure QOL, as well as on the rapidly growing field of electronic questionnaire administration.
This event is meant to stimulate progress and ensure greater patient involvement in cancer clinical trials, hence, patients and patient advocates will be speaking and providing their unique vision on QOL. All academic attendees will be able to participate for free.
Finally, we would like to thank our sponsors, including the EORTC Quality of Life Group, for supporting this conference.
We are all looking forward to welcoming you to our conference and participating in an engaging exchange of ideas.
Dr. Andrew Bottomley (Conference Chair), and Drs. Jaap Reijneveld, Michael Koller, Henning Flechtner, Krzysztof Tomaszewski and Eva Greimel (Conference Co- Chairs)
Find the conference’s website here.